AA
SLS icon

ALPS Advisors’s SELLAS Life Sciences SLS Stock Holding History

ALPS Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Buy
+188,107
New +$1.3M 0.01% 425

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return

ALPS Advisors's SLS Position: Q2 2026 in Review

ALPS Advisors opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 188,107 shares worth $2.78M. The stake represents 0.01% of the portfolio and ranks #425 among its holdings.

48 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • ALPS Advisors held 188,107 shares of SELLAS Life Sciences worth $2.78M as of Q2 2026.
  • SELLAS Life Sciences was a new ALPS Advisors position in Q2 2026.
  • SELLAS Life Sciences made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #425 holding.
  • 48 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.